KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Recursion Pharmaceuticals (RXRX) Capital Leases: 2020-2021

Historic Capital Leases for Recursion Pharmaceuticals (RXRX) over the last 1 years, with Dec 2021 value amounting to $9.3 million.

  • Recursion Pharmaceuticals' Capital Leases rose 244.87% to $9.3 million in Q4 2021 from the same period last year, while for Dec 2021 it was $9.3 million, marking a year-over-year increase of 244.87%. This contributed to the annual value of $9.3 million for FY2021, which is 244.87% up from last year.
  • Latest data reveals that Recursion Pharmaceuticals reported Capital Leases of $9.3 million as of Q4 2021, which was up 169.91% from $3.5 million recorded in Q3 2021.
  • In the past 5 years, Recursion Pharmaceuticals' Capital Leases registered a high of $9.3 million during Q4 2021, and its lowest value of $2.4 million during Q2 2021.
  • Over the past 2 years, Recursion Pharmaceuticals' median Capital Leases value was $2.7 million (recorded in 2020), while the average stood at $4.1 million.
  • Data for Recursion Pharmaceuticals' Capital Leases shows a peak YoY spiked of 244.87% (in 2021) over the last 5 years.
  • Over the past 2 years, Recursion Pharmaceuticals' Capital Leases (Quarterly) stood at $2.7 million in 2020, then spiked by 244.87% to $9.3 million in 2021.
  • Its Capital Leases was $9.3 million in Q4 2021, compared to $3.5 million in Q3 2021 and $2.4 million in Q2 2021.